Mix-and-match COVID vaccines: the case is growing, but questions remain - Nature

A slew of studies suggests that mixing vaccines provokes potent immune responses, but scientists still want answers on real-world efficacy and rare side effects.

https://www.nature.com/articles/d41586-021-01805-2

vanillam 認為含有正確訊息

回應於 1,003 天前｜引用自 vanillam 查核回應

關於年青人接種mRNA疫苗研究報告 https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

《自然》科學期刊關於混打疫苗文章
https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

提醒：疫苗相關的醫學研究資訊每天都有新突破或報告。

資料佐證

https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

COVID-19 and balancing the risks: The vaccine or the virus

Given reports of myocarditis after vaccination with mRNA-based COVID-19 vaccines in young people, it's a good time to reexamine their risk/benefit ratio.

https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

COVID-19 and balancing the risks: The vaccine or the virus

Given reports of myocarditis after vaccination with mRNA-based COVID-19 vaccines in young people, it's a good time to reexamine their risk/benefit ratio.

https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

COVID-19 and balancing the risks: The vaccine or the virus

Given reports of myocarditis after vaccination with mRNA-based COVID-19 vaccines in young people, it's a good time to reexamine their risk/benefit ratio.

https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

COVID-19 and balancing the risks: The vaccine or the virus

Given reports of myocarditis after vaccination with mRNA-based COVID-19 vaccines in young people, it's a good time to reexamine their risk/benefit ratio.

https://sciencebasedmedicine.org/covid-19-and-balancing-the-risks-the-vaccine-or-the-virus/

以上內容由「Cofacts 真的假的」訊息回報機器人與查證協作社群提供，以 CC授權姓名標示-相同方式分享 4.0 (CC BY-SA 4.0) 釋出，於後續重製或散布時，原社群顯名及每一則查證的出處連結皆必須被完整引用。